ConductScience.org, home

Paper32259264

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.

Yu Y and 9 others. JAMA Netw Open, 2020. Cited by 83 papers, by iCite.

Cite this record

ConductScience Library. Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer. Papers, record 32259264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32259264

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
PubMed
Journal
JAMA Netw Open
PubMed
Year
2020
PubMed
Publication types
Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
3.32
iCite
Revised in PubMed
2020-10-23
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu YYunfang
2Zhang WWenda
3Li AAnlin
4Chen YYongjian
5Ou QQiyun
6He ZZifan
7Zhang YYiwen
8Liu RRuixin
9Yao HHerui
10Song EErwei

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunotherapyMajor topic
NeoplasmsMajor topic
RNA, Long NoncodingMajor topic
Adult
Aged
Algorithms
B7-H1 Antigen
Biomarkers
Case-Control Studies
China
Cohort Studies
Disease-Free Survival
Female
Humans
Male
Melanoma
Middle Aged
T-Lymphocytes, Cytotoxic
Tumor Burden
Urinary Bladder Neoplasms

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
230936474Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells.Nat Cell Biol2019https://conductscience.org/library/papers/30936474PubMed
325569120Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.BMJ2015https://conductscience.org/library/papers/25569120PubMed
430127393Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.Nat Med2018https://conductscience.org/library/papers/30127393PubMed
531290993Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.JAMA Netw Open2019https://conductscience.org/library/papers/31290993PubMed
631436822Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1.JAMA Oncol2019https://conductscience.org/library/papers/31436822PubMed
724071849The Cancer Genome Atlas Pan-Cancer analysis project.Nat Genet2013https://conductscience.org/library/papers/24071849PubMed
829541787Quantifying tumor-infiltrating immune cells from transcriptomics data.Cancer Immunol Immunother2018https://conductscience.org/library/papers/29541787PubMed
929395328CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness.Cell2018https://conductscience.org/library/papers/29395328PubMed
1030224822NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death.Nat Immunol2018https://conductscience.org/library/papers/30224822PubMed
1124138885Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.Immunity2013https://conductscience.org/library/papers/24138885PubMed
1225759022A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis.Cancer Cell2015https://conductscience.org/library/papers/25759022PubMed
1310877287Time-dependent ROC curves for censored survival data and a diagnostic marker.Biometrics2000https://conductscience.org/library/papers/10877287PubMed

Download CSV of references

Cited by75

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
42500647Long non-coding RNAs and their potential role in predicting immunotherapy response and prognosis: a systematic review.Front Immunol2026https://conductscience.org/library/papers/42500647PubMed
41454405Long non-coding RNAs in the tumor immune microenvironment of non-small cell lung cancer: mechanisms and clinical translational perspectives.J Transl Med2025https://conductscience.org/library/papers/41454405PubMed
40490527Tumor-associated macrophages-induced lncRNA RP11-627G18.1 promotes breast cancer metastasis.Genes Immun2025https://conductscience.org/library/papers/40490527PubMed
40342408Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors.Front Immunol2025https://conductscience.org/library/papers/40342408PubMed
40282449Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting.Cancers (Basel)2025https://conductscience.org/library/papers/40282449PubMed
39968500Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer.MedComm (2020)2025https://conductscience.org/library/papers/39968500PubMed
39917986Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review).Int J Oncol2025https://conductscience.org/library/papers/39917986PubMed
39812052Using Multi-Omics Methods to Understand Gouty Arthritis.Curr Rheumatol Rev2026https://conductscience.org/library/papers/39812052PubMed
39725831Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer.Clin Transl Oncol2025https://conductscience.org/library/papers/39725831PubMed
39712455Combined pyrotinib and fulvestrant for hormone receptor-positive and HER2-positive metastatic breast cancer: A multicenter, single-arm, phase II trial.MedComm (2020)2025https://conductscience.org/library/papers/39712455PubMed
39669975Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer.MedComm (2020)2024https://conductscience.org/library/papers/39669975PubMed
39633711Noncoding RNA, friend or foe for nephrolithiasis?Front Cell Dev Biol2024https://conductscience.org/library/papers/39633711PubMed
39242755LncRNA sequencing reveals an essential role for the lncRNA-mediated ceRNA network in penile squamous cell carcinoma.Genes Immun2024https://conductscience.org/library/papers/39242755PubMed
39000359Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives.Int J Mol Sci2024https://conductscience.org/library/papers/39000359PubMed
38756447Deciphering the role of apoptosis signature on the immune dynamics and therapeutic prognosis in breast cancer: Implication for immunotherapy.Front Genet2024https://conductscience.org/library/papers/38756447PubMed
38720108Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion.Discov Oncol2024https://conductscience.org/library/papers/38720108PubMed
38546403The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.Aging (Albany NY)2024https://conductscience.org/library/papers/38546403PubMed
38495207Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy.Heliyon2024https://conductscience.org/library/papers/38495207PubMed
38434763Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single-cell RNA sequencing.MedComm (2020)2024https://conductscience.org/library/papers/38434763PubMed
38372785Current look at the most promising proteomic and glycomic biomarkers of bladder cancer.J Cancer Res Clin Oncol2024https://conductscience.org/library/papers/38372785PubMed

See all 75 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32259264

GET https://conductscience.org/api/papers/v1/32259264/cited_by?page=2